🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In patients with previously untreated Marginal zone lymphoma (MZL), a treat...
Status
Active Not Recruiting
Location
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing,
Start Date
2025-10-01
Trial ID
NCT07480863
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of orelabr...
Status
Unknown
Location
The first affiliated hospital of bengbu medical college
Start Date
2022-11-02
Trial ID
NCT05234684
Treatments Being Tested
The study is designed to be a randomized, open, multi-center, phase IIa/IIb...
Status
Unknown
Location
Hainan People's Hospital
Start Date
2022-02-21
Trial ID
NCT05232149
Treatments Being Tested
Efficacy and Safety of Orelabrutinib Combined with Rituximab versus Lenalid...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2023-12-19
Trial ID
NCT06082102
Treatments Being Tested
This is an Open-Label, Parallel, Single-dose, Phase I Clinical Study to Eva...
Status
Unknown
Location
The First Affilitaed Hospital of Bengbu Medical College
Start Date
2023-03-17
Trial ID
NCT05684653
Treatments Being Tested
This is a prospective, multicenter Phase 2 clinical trial named the MALT-RO...
Status
Recruiting
Location
No. 1, East Banshan Road , Gongshu District
Start Date
2026-04-16
Trial ID
NCT07554898
Treatments Being Tested
Exploring the efficacy and safety of first-line treatment of primary centra...
Status
Completed
Location
The First Affiliated Hospital of Ningbo University
Start Date
2021-12-28
Trial ID
NCT06454266
Treatments Being Tested
The purpose of the study is to assess the Safety, Tolerability, PK/PD and p...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-07-09
Trial ID
NCT04305197
Prospective, interventional, and practical clinical studies...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-24
Trial ID
NCT06476899
Treatments Being Tested
Obrutinib is a highly selective BTKi and has shown efficacy in CLL/MCL. Thi...
Status
Unknown
Location
Multiple Locations
Start Date
2021-09-01
Trial ID
NCT05014100
Treatments Being Tested